|
| |
| | 63172 | | 10.06.2014 | | Roche Pharma (Schweiz) AG | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Gazyvaro 1000 mg/40 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Obinutuzumabum 1000mg / 40ml) | L01FA03 | |
|
|
|